Anhui Huaren Health Pharmaceutical Co., Ltd. (SHE:301408)
China flag China · Delayed Price · Currency is CNY
14.93
+0.26 (1.77%)
At close: Sep 30, 2026

SHE:301408 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,001957.971,0021,336482.1284.51
Trading Asset Securities
32221012.41-0.5
Cash & Short-Term Investments
1,033979.971,0121,349482.1285.01
Cash Growth
21.71%-3.13%-24.99%179.76%69.16%23.37%
Accounts Receivable
515.11588.83472.6513.14470.77294.32
Other Receivables
8.549.68.8136.2434.5230.82
Receivables
523.65598.43481.42549.38505.29325.14
Inventory
1,0691,055863.84772.09545.01436.19
Prepaid Expenses
13.6113.5515.638.272.524.22
Other Current Assets
244.85266.34224.87147.78165.2262.74
Total Current Assets
2,8842,9132,5972,8261,7001,113
Property, Plant & Equipment
990.46985967.8870.15533.42542.53
Long-Term Investments
45.5245.5282.292.8125.458.92
Goodwill
1,2991,282988.37609.31190.06190.06
Other Intangible Assets
62.2263.967.2162.51338.26
Long-Term Deferred Tax Assets
48.5451.7840.6532.8321.9215.17
Long-Term Deferred Charges
82.2382.9659.0352.1158.9792.32
Other Long-Term Assets
56.6263.8425.4865.7413.230.5
Total Assets
5,4685,4884,8284,6122,5761,971

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
1,4841,6661,1581,027698.74468.23
Accrued Expenses
160.99174.24140.2599.84101.6879.98
Short-Term Debt
560.89345.3316.92513.51340.31150.77
Current Portion of Long-Term Debt
147.39179.36116.0210.25--
Current Portion of Leases
215.46199.71210.44193.64154.24144
Current Income Taxes Payable
24.9138.1420.6312.334.6313.15
Current Unearned Revenue
38.1742.8637.1127.0619.4111.25
Other Current Liabilities
37.0939.74178.9480.3112.715.25
Total Current Liabilities
2,6692,6862,1791,9641,362882.64
Long-Term Debt
409.62407.08358.83331.1518.95-
Long-Term Leases
203.12220.08222.85237.65248.51303.03
Long-Term Unearned Revenue
1.991.810.810.91--
Long-Term Deferred Tax Liabilities
5.976.26.656.32--
Other Long-Term Liabilities
4.54.5-95.4-0.33
Total Liabilities
3,2943,3252,7682,6351,6291,186

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
400.01400.01400.01400.01340340
Additional Paid-In Capital
842.8916.8977.861,014194.7192.99
Retained Earnings
876.08780.17627.42529.39412.58251.81
Total Common Equity
2,1192,0972,0051,944947.28784.8
Minority Interest
54.9166.1355.1433-0.270.25
Shareholders' Equity
2,1742,1632,0601,977947.01785.05
Total Liabilities & Equity
5,4685,4884,8284,6122,5761,971

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
1,5361,3521,2251,286762.02597.8
Net Cash (Debt)
-503.6-371.57-213.4362.53-279.92-312.8
Net Cash Growth
------
Net Cash Per Share
-1.26-0.93-0.530.16-0.82-0.94
Filing Date Shares Outstanding
400.01400.01400.01400.01340340
Total Common Shares Outstanding
400.01400.01400.01400.01340340
Working Capital
214.34227.37418.84862.52338.42230.65
Book Value Per Share
5.305.245.014.862.792.31
Tangible Book Value
757.61750.67949.711,272724.22586.49
Tangible Book Value Per Share
1.891.882.373.182.131.72
Buildings
404.76382.39219.2238.7323.1523.15
Machinery
341.5337.07297.24270.1679.3865.74
Construction In Progress
35.9134.73168.6661.3432.240.25